PMID- 12011256 OWN - NLM STAT- MEDLINE DCOM- 20020723 LR - 20171116 IS - 0893-3952 (Print) IS - 0893-3952 (Linking) VI - 15 IP - 5 DP - 2002 May TI - A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. PG - 517-25 AB - Mantle cell lymphoma (MCL) diagnosis first relies on morphology and phenotype that may overlap with other B-cell lymphomas. Therefore, the demonstration of t(11;14)(q13;q32), the cytogenetic hallmark of MCL, is considered of diagnostic value. By studying a series of 35 MCL with characteristic morphology and phenotype (CD5+, CD10-, CD20+, CD23-), we have evaluated the applicability and the sensitivity of interphase fluorescence in situ hybridization (FISH) for t(11;14) detection and other techniques: (1) polymerase chain reaction (PCR) for amplification of t(11;14) genomic breakpoint, (2) competitive RT-PCR for the detection of cyclin D1 transcripts overexpression, and (3) immunohistochemistry (IHC) for cyclin D1 protein detection. Tissues from different origins were analyzed: lymph nodes (n = 24), spleen (n = 3), digestive biopsy (n = 3), tonsils (n = 3), and skin (n = 2). Interphase FISH was performed either on touch preparations (n = 11) and frozen (n = 9) or paraffin sections (n = 15). FISH analysis detected t(11;14) in 34/35 cases (97%) and demonstrated a recurrent CCND1 amplification in t(11;14)+ nuclei of the three blastoid MCL variants of our series. Genomic PCR analysis, hampered by the scattering of 11q13 breakpoints, was positive in only 13/35 cases (37%). RT-PCR analysis was applicable on nonepithelial tissues (27/35) and showed cyclin D1 transcript overexpression in all tested cases (27/35). IHC for cyclin D1 protein was performed either on frozen (n = 12) or on paraffin sections (n = 23), and its sensitivity was higher on paraffin sections (91%) than on frozen sections (25%). A cyclin D1 protein immunoreactivity was observed in 24/35 cases (69%). Our study emphasizes on the use of FISH analysis for the direct detection of t(11;14) because its applicability and sensitivity largely exceeded those of other techniques. It may also provide some informations on secondary cytogenetic changes of potential clinical relevance. FAU - Belaud-Rotureau, Marc-Antoine AU - Belaud-Rotureau MA AD - Department of Histology and Molecular Pathology, Victor Segalen University, Bordeaux, France. jp.merlio@histo.u-bordeaux2.fr FAU - Parrens, Marie AU - Parrens M FAU - Dubus, Pierre AU - Dubus P FAU - Garroste, Jean-Christophe AU - Garroste JC FAU - de Mascarel, Antoine AU - de Mascarel A FAU - Merlio, Jean-Philippe AU - Merlio JP LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Mod Pathol JT - Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc JID - 8806605 RN - 0 (Antigens, CD20) RN - 0 (CD5 Antigens) RN - 0 (DNA, Neoplasm) RN - 0 (RNA, Messenger) RN - 136601-57-5 (Cyclin D1) SB - IM MH - Antigens, CD20/analysis MH - Blotting, Southern MH - CD5 Antigens/analysis MH - Chromosomes, Human, Pair 11/genetics MH - Chromosomes, Human, Pair 14/genetics MH - Cyclin D1/analysis/genetics MH - DNA, Neoplasm/genetics MH - Humans MH - Immunohistochemistry MH - In Situ Hybridization, Fluorescence MH - Lymphoma, Mantle-Cell/genetics/metabolism/*pathology MH - Polymerase Chain Reaction MH - RNA, Messenger/genetics/metabolism MH - Reverse Transcriptase Polymerase Chain Reaction MH - Translocation, Genetic EDAT- 2002/05/16 10:00 MHDA- 2002/07/24 10:01 CRDT- 2002/05/16 10:00 PHST- 2002/05/16 10:00 [pubmed] PHST- 2002/07/24 10:01 [medline] PHST- 2002/05/16 10:00 [entrez] AID - 10.1038/modpathol.3880556 [doi] PST - ppublish SO - Mod Pathol. 2002 May;15(5):517-25. doi: 10.1038/modpathol.3880556.